interface was dissected and analyzed via electron dispersion spectroscopy(EDS) and scanning electron microscopy(SEM).
INTRODUCTION AND OBJECTIVES:
In the past 10 years, the gut microbiome (GMB) has been recognized as an important determinant of human health. Recent advances in sequencing of the human GMB have led to important breakthroughs that describe its relationship to diverse and important human health outcomes such as asthma, inflammatory bowel disease, and cardiovascular disease. However, the study of the gut microbiome in the field of benign urology is in its infancy. The Genetic Hypercalciuric Stone-forming (GHS) rat is an established model of kidney stone disease and has been selectively inbred for hypercalciuria, originally from standard Sprague Dawley (SD) rats. All GHS rats make stones by 18 weeks of age. The model has been extensively studied and phenotyped. However, no study has previously examined differences in the rats' microbiome. In this study we characterize the gut microbiome (GMB) from GHS rats compared to age and sex matched SD rats.
METHODS: 4 male GHS rats and 2 male SD rats were housed separately and fed similar diets of rat chow in the same animal room. Fresh fecal pellets were collected at one single time point, stored at -80 degrees celsius and sent to the Albert Einstein Department of Urology where the pellets were prepared for analysis by DNA extraction, amplification of the 16S rRNA V4 region using barcoded primers on an Illumina platform. QIIME was used for analysis.
RESULTS: 16s rRNA analysis between the 2 groups found significant differences. The alpha diversity of the GHS rats' GMB clustered well and was widely separated from SD. The GHS rats had a lower Shannon score diversity. Bacteroides genus was 39% more abundant in the GHS, similar to that found in our clinical study of stone formers. Roseburia genus, known to contain species that produce beneficial short chain fatty acids, was 70% more abundant in the SD group. Similarly Faecalibacterium genus, with known butyrate producers, was increased 35% in the SD rats.
CONCLUSIONS: We demonstrate that age, diet and sex matched GHS rats have a GMB that is distinct from its SD ancestors. Of particular interest is the decreased bacterial diversity seen in these rats. Bacteroides genera is significantly up-regulated in the GHS rats and similar to findings seen in human stone formers. Future studies to identify the role the GMB has in modulating USD risk are needed.
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PD03-03 GENOTYPE CLASSIFICATION BASED ON THE MULTIPLE CYSTINE RELATED TRANSPORTERS IN JAPANESE CYSTINURIA PATIENTS
Shinichi Sakamoto*, Akinori Takei, Chiba, Japan; Takaaki Tamura, Yokohama, Japan; Masaaki Fujimura, Chiba, Japan; Yasuhiro Shigeta, Funbashi, Japan; Yusuke Imamura, Chiba, Japan; Hitoshi Yano, Sakura, Japan; Yukio Naya, Anegasaki, Japan; Koji Kawamura, Takashi Imamoto, Akira Komiya, Chiba, Japan; Koichiro Akakura, Shinjuku, Japan; Tomohiko Ichikawa, Chiba, Japan INTRODUCTION AND OBJECTIVES: Cystinuria is known to be a disease with autosomal recessive inheritance. However, based on our previous analysis, 13% of patients possessed a single heterozygote mutation and a few patients without any mutation. Last year, a novel cysteine transporter: AGT1 was also identified. Based on this fact, we investigated two possibilities: 1) mutation in intron-exon boundary and 2) mutation among different transporter including a novel AGT1 transporter. To solve the missing part, we performed a next-generation sequence of Japanese Cystinuria patients.
METHODS: A next-generation sequence was performed among 16 patients who previously performed a direct sequence of SLC3A1/SCL7A9, including one patient without any mutation. Nextseq 500 was used for the sequencing. The result between previous direct sequence and a next-generation sequence were compared.
RESULTS: The median concentration of Cystine was 1758.8mM. Ten patients (63%) possessed P482L homozygote mutation, and five patients (32%) possessed heterozygote mutations. In the patient previously without any mutation identified, two frameshift mutation c.873+2dupT and c.611_612delCA in the intron-exon boundary. Additional frameshift mutation: p.Val340fs was identified in two patients previously identified only a single P482L heterozygote mutation. In novel AGT1 transporter, a single nucleotide polymorphism: A380L, M452T, and Ter471fs were identified. Except for Cystine transporter, multiple mutations were also identified in SLC26A1, SLC26A7, and SL13A2 that are related to the maintenance of urine pH and citrate reabsorption.
CONCLUSIONS: Three novel mutations were identified includes one in exon-intron boundary (c.873+2dupT) and two frameshifts (c.611_612delCA and p.Val340fs) by a next-generation sequence. Based on the result, all the patients had at least two mutations in SLC3A1/SCL7A9 that fit for the autosomal recessive inheritance. Current data also indicated the SNPs in AGT1 and mutations in urine pH related transporters could potentially contribute to the phenotype of the Cystinuria. Based on the genotypes of multiple transporters we may subclassify the risk of Cystinuria patients. None Vol. 199, No. 4S, Supplement, Friday, May 18, 2018 THE JOURNAL OF UROLOGY â e71
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